AI assistant
AROA BIOSURGERY LIMITED — Director's Dealing 2024
Aug 22, 2024
64426_rns_2024-08-22_4538dda2-f700-47d6-9f9c-b75389696717.pdf
Director's Dealing
Open in viewerOpens in your device viewer
Appendix 3Y Change of Director’s Interest Notice
Rule 3.19A.2
Appendix 3Y
Change of Director’s Interest Notice
Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.
Introduced 30/09/01 Amended 01/01/11
Name of entity Aroa Biosurgery Limited ARBN 638 867 473
We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.
| Name of Director | Darla Hutton |
|---|---|
| Date of last notice | 22 March 2024 |
Part 1 - Change of director’s relevant interests in securities
In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust
Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Direct or indirect interest | Direct |
|---|---|
| Nature of indirect interest(including registered holder)Note: Provide details of the circumstances giving rise to therelevant interest. | N/A |
| Date of change | 22 August 2024 |
| No. of securities held prior to change | Nil |
| Class | Fully Paid Ordinary Shares |
| Number acquired | 140,110 Fully Paid Ordinary Shares |
| Number disposed | - |
| Value/ConsiderationNote: If consideration is non-cash, provide details and estimatedvaluation | $40,000 NZD |
| No. of securities held after change | 140,110 Fully Paid Ordinary Shares |
- See chapter 19 for defined terms.
01/01/2011
Appendix 3Y Page 1
Appendix 3Y Change of Director’s Interest Notice
Nature of change Issued on 22 August 2024 pursuant to Example: on-market trade, off-market trade, exercise of options, shareholder approval received at the Annual issue of securities under dividend reinvestment plan, participation in buy-back General Meeting held on 23 July 2024.
Part 2 – Change of director’s interests in contracts
Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.
| Detail of contract | - |
|---|---|
| Nature of interest | - |
| Name of registered holder(if issued securities) | - |
| Date of change | - |
| No. and class of securities to which interestrelated prior to changeNote: Details are only required for a contract in relation to which the interesthas changed | - |
| Interest acquired | - |
| Interest disposed | - |
| Value/ConsiderationNote: If consideration is non-cash, provide details and an estimatedvaluation | - |
| Interest after change | - |
Part 3 –[+] Closed period
| Were the interests in the securities orcontracts detailed above traded during a+closedperiodwherepriorwrittenclearance was required? | No |
|---|---|
| If so, was prior written clearance providedto allow the trade to proceed during thisperiod? | N/A |
| If prior written clearance was provided, onwhat date was this provided? | N/A |
- See chapter 19 for defined terms.
Appendix 3Y Page 2
01/01/2011